Many people with Down syndrome will show signs of decline as they age, often associated with the presence of Alzheimer's disease. These signs often begin in their early 50s and will affect their lives and health. Worry and concern about this disease and its implications for self-care, supports, health, and quality of life can be very unsettling.
The recent news of new medications that may hold promise in making a difference for persons diagnosed with Alzheimer's disease needs clarification, perspective, and an understanding of how they may help adults with Down syndrome, and possibly adults with other intellectual disabilities.
The NTG is pleased to bring together a national panel of expert researchers and practitioners in the field of Down syndrome and Alzheimer's disease who will engage in a realistic and thoughtful discussion of both current and future therapeutics, matters related to diagnostics, and the emerging research on biomarkers. We see this webinar as useful to parents and families, providers, advocates, clinicians, practitioners, and others invested in the future for persons with Down syndrome. Come join us, listen, and engage our panelists with your questions.
This webinar is free to the public. The webinar will be recorded and a link to the recording sent to all registered participants unable to attend the live webinar following the webinar.
5:00 pm EDT
4:00 pm Central Time
3:00 pm Mountain Time
2:00 PM Pacific Daylight Time
11:00 AM Hawaii-Aleutian Standard Time